MeiraGTx Holdings plc (NASDAQ:MGTX - Get Free Report)'s stock price traded up 10.1% on Friday . The stock traded as high as $6.43 and last traded at $6.43. 214,661 shares traded hands during trading, an increase of 5% from the average session volume of 205,181 shares. The stock had previously closed at $5.84.
Analysts Set New Price Targets
A number of research firms have weighed in on MGTX. Royal Bank of Canada upped their price target on shares of MeiraGTx from $9.00 to $11.00 and gave the stock an "outperform" rating in a research report on Thursday, November 14th. Chardan Capital reaffirmed a "buy" rating and issued a $36.00 target price on shares of MeiraGTx in a report on Monday, November 18th.
Read Our Latest Report on MeiraGTx
MeiraGTx Price Performance
The company has a current ratio of 2.34, a quick ratio of 2.34 and a debt-to-equity ratio of 0.86. The company has a market cap of $480.64 million, a P/E ratio of -5.08 and a beta of 1.25. The firm has a 50 day moving average of $6.12 and a 200-day moving average of $4.96.
Hedge Funds Weigh In On MeiraGTx
Hedge funds have recently modified their holdings of the stock. Panagora Asset Management Inc. bought a new stake in MeiraGTx in the 2nd quarter valued at $97,000. Privium Fund Management B.V. increased its holdings in shares of MeiraGTx by 70.0% in the second quarter. Privium Fund Management B.V. now owns 203,960 shares of the company's stock worth $804,000 after purchasing an additional 83,975 shares during the last quarter. Rhumbline Advisers lifted its position in shares of MeiraGTx by 10.8% in the second quarter. Rhumbline Advisers now owns 52,996 shares of the company's stock worth $223,000 after buying an additional 5,178 shares in the last quarter. Letko Brosseau & Associates Inc. boosted its stake in MeiraGTx by 38.5% during the second quarter. Letko Brosseau & Associates Inc. now owns 45,300 shares of the company's stock valued at $191,000 after buying an additional 12,600 shares during the last quarter. Finally, American Century Companies Inc. boosted its stake in MeiraGTx by 42.4% during the second quarter. American Century Companies Inc. now owns 40,008 shares of the company's stock valued at $168,000 after buying an additional 11,907 shares during the last quarter. Hedge funds and other institutional investors own 67.48% of the company's stock.
About MeiraGTx
(
Get Free Report)
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.
Featured Stories
Before you consider MeiraGTx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MeiraGTx wasn't on the list.
While MeiraGTx currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
